BioLase Inc. buy Ascendiant Capital Markets
Start price
03.09.24
/
50%
€0.067
Target price
03.09.25
€1.81
Performance (%)
-
End price
04.09.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioLase Inc. | - | - | - |
| iShares Core DAX® | -0.201% | 5.471% | 9.188% |
| iShares Nasdaq 100 | 2.573% | 10.092% | 39.291% |
| iShares Nikkei 225® | 0.598% | 9.871% | 46.201% |
| iShares S&P 500 | 1.804% | 7.404% | 29.617% |
Comments by Ascendiant_Capital_M for this prediction
In the thread BioLase Inc. diskutieren
BIOLASE, Inc. (NASDAQ: BIOL) had its price target lowered by analysts at Ascendiant Capital Markets from $3.50 to $2.00. They now have a "buy" rating on the stock.
Ratings data for BIOL provided by MarketBeat
In the thread Trading BioLase Inc.
Die von Ascendiant_Capital_M gewählte maximale Laufzeit wurde überschritten